Investor Presentaiton slide image

Investor Presentaiton

FY2024 Forecast by Segment Basic chemicals: The impact of malfunctions in AC production facilities will be mitigated Functional chemicals Maintain and expand sales share Healthcare Continue to perform strongly due to growth in demand FY2022* FY2023 Forecast Change (YoY) (Million of yen) 1H 2H Full Year 1H 2H Full Year 1H 2H Full Year Basic Chemicals 20,986 21,336 42,322 18,266 23,634 41,900 (2,720) 2,298 (422) Functional Chemicals 15,201 16,659 31,860 13,477 16,423 29,900 (1,724) (236) (1,960) Net sales Healthcare 5,273 5,002 10,275 5,372 6,228 11,600 99 1,226 1,325 Trading and Others 10,454 9,296 19,750 9,507 12,093 21,600 (947) 2,797 1,850 Total 51,915 52,293 104,208 46,622 58,378 105,000 (5,293) 6,085 792 Basic Chemicals 3,730 1,118 4,848 59 541 600 (3,671) (577) (4,248) Functional Chemicals 3,951 2,447 6,398 2,107 2,043 4,150 (1,844) (404) (2,248) Healthcare 2,307 2,308 4,615 2,661 2,689 5,350 354 381 735 Operating income Trading and Others 381 607 988 698 452 1,150 317 (155) 162 Company-wide, (648) (645) (1,293) (609) (641) (1,250) 39 4 43 eliminations Total 9,722 5,835 15,557 4,917 5,083 10,000 (4,805) (752) (5,557) *Figures by segment for FY2022 are approximate figures reclassified into new segments Something Better with Chemicals OSAKA SODA 12
View entire presentation